Suppr超能文献

用于中风治疗的诊断和介入放射学进展:从试验到床边的历程,历经MR CLEAN之前、MR CLEAN以及MR CLEAN II时代

Advancements in diagnostic and interventional radiology for stroke treatment: the path from trial to bedside through the pre-MR CLEAN, MR CLEAN, and MR CLEAN II eras.

作者信息

Samuels Noor, van de Graaf Rob A, Roos Yvo B W M, Dippel Diederik, van der Lugt Aad

机构信息

Department of Radiology and Nuclear Medicine, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.

Department of Neurology, Amsterdam University Medical Center, Location AMC, Amsterdam, the Netherlands.

出版信息

Insights Imaging. 2024 Jan 30;15(1):30. doi: 10.1186/s13244-023-01597-1.

Abstract

The stroke field is inevitably connected with imaging in which radiologists fulfill a central role. Our landmark MR CLEAN trial led to the implementation of baseline computed tomography angiography or magnetic resonance angiography in the acute stroke workup and subsequent endovascular treatment (EVT) for ischemic stroke patients with a large vessel occlusion in the anterior circulation, resulting in numerous patients worldwide currently being treated often successfully. A reversal of the pathophysiologic process behind an acute cerebrovascular event was made possible. Subsequently, in the MR CLEAN II trials, the clinical impact of both diagnostic and interventional radiologists remained a cornerstone of our research, which means value-based radiology. Within these MR CLEAN II trials, we proved that aspirin and heparin during EVT should be avoided due to increased symptomatic intracranial hemorrhage risk (MR CLEAN-MED). We concluded there is additional benefit of EVT in the 6-to-24-h window after stroke in the presence of good collaterals on baseline CTA (MR CLEAN-LATE). The impactful success of our stroke trials that changed many guidelines was mainly attributable to (1) the societal burden of the disease, with two thirds of patients dying or being independent at 3 months; (2) the fact that stroke is a common disease, (3) the relatively simple and pragmatic approach of the trials resembling real-world setting; (4) the acceleration of implementation in clinical practice facilitated by a structured approach to guideline development and conditional funding; and foremost (5) the excellent collaboration on a professional level between-disciplines, i.e., diagnostic radiologists, interventionalists, and neurologists.Critical relevance statement The MR CLEAN and MR CLEAN II trials have had tremendous impact on clinical practice, directly by more patients being treated with an effective intervention and indirectly through adoption of evidence-based guidelines. It is in this setting of stroke treatment that diagnostic and interventional radiologists have played a crucial role and created clinical impact.

摘要

卒中领域不可避免地与影像学相关联,放射科医生在其中发挥着核心作用。我们具有里程碑意义的MR CLEAN试验促使在急性卒中检查中实施基线计算机断层血管造影或磁共振血管造影,并随后对前循环大血管闭塞的缺血性卒中患者进行血管内治疗(EVT),这使得全球众多患者目前常常得到成功治疗。急性脑血管事件背后的病理生理过程得以逆转。随后,在MR CLEAN II试验中,诊断和介入放射科医生的临床影响仍然是我们研究的基石,这意味着基于价值的放射学。在这些MR CLEAN II试验中,我们证明由于症状性颅内出血风险增加,在EVT期间应避免使用阿司匹林和肝素(MR CLEAN-MED)。我们得出结论,在基线CTA显示侧支循环良好的情况下,卒中后6至24小时内进行EVT有额外益处(MR CLEAN-LATE)。我们的卒中试验取得了重大成功,改变了许多指南,这主要归因于:(1)该疾病的社会负担,三分之二的患者在3个月时死亡或独立;(2)卒中是一种常见疾病这一事实;(3)试验采用的相对简单且务实的方法类似于现实世界的情况;(4)通过结构化的指南制定方法和有条件的资金支持,加速了在临床实践中的实施;最重要的是(5)诊断放射科医生、介入专家和神经科医生等学科之间在专业层面的出色合作。关键相关性声明MR CLEAN和MR CLEAN II试验对临床实践产生了巨大影响,直接表现为更多患者接受了有效的干预治疗,并通过采用循证指南间接产生影响。正是在这种卒中治疗背景下,诊断和介入放射科医生发挥了关键作用并产生了临床影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e61/10828318/0c9d7fef57ea/13244_2023_1597_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验